Retinoids and Substances of Abuse in HIV-1 Infection

HIV-1 感染中的类视黄醇和滥用物质

基本信息

  • 批准号:
    6627806
  • 负责人:
  • 金额:
    $ 34.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-05-15 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant) Neurologic disease in HIV infection has been associated with damage to nervous system tissue induced by pro-inflammatory cytokines and other soluble factors that are released by activated mononuclear phagocytes (MP). In this proposal, we will examine mechanisms by which retinoids suppress pro-inflammatory activity in immune cells from individuals with HIV infection and in immune cell lines. Retinoids, which are vitamin A-related compounds, have been demonstrated to suppress such immune activity, and, in studies of m -1 infection, can suppress replication of virus in infected mononuclear cell lines. Among individuals with HIV-1 (HIV) infection, vitamin A deficiency has been associated with an increased risk of developing HIV-related complications. However, in most cases, the administration of vitamin A in clinical trials has not been associated with improvement in HIV-related clinical parameters. Our prior studies demonstrate that 1) parameters of vitamin A metabolism in plasma are lower among HIV-infected individuals than among non-infected subjects and suggest that such abnormalities can be observed in CSF; 2) plasma retinol levels are lower in seronegative patients with chronic inflammatory neurologic disease than in control subjects with non-inflammatory neurologic disease and treatment of these individuals with an immunomodulatory agent is associated with specific effects on retinoid receptor subtype expression patterns; 3) retinoid compounds suppress pro-inflammatory cytokine production by peripheral blood immune cells and cell lines and that, in the cell lines, retinoid-induced suppressive activity can be inhibited by simultaneous exposure of the cells to morphine or cocaine. Therefore, we propose the following aims for this proposal: 1) to examine the expression of pro-inflammatory cytokine (TNF-a) by mononuclear cells from opiate users and non-drug users with or without a history of HIV infection; 2) to examine the effects of specific retinoid receptor activation on the immune effects elicited in retinoid-exposed mononuclear cell lines; 3) to examine the effects of substances of abuse (morphine and cocaine) on specific immune responses induced by retinoid receptor agonists and receptor antagonists in mononuclear cell lines; and 4) and to assess the role of inhibition of nuclear NF-KB binding in the effects of retinoids and substances of abuse on pro-inflammatory cytokine production by the patient cells and by the mononuclear cell lines. These studies will broaden our understanding of the immune effects of retinoid compounds in individuals with HIV infection, and may lead to effective approaches to the treatment of the infection and its complications with vitamin A.
描述:(由申请人提供)HIV 感染引起的神经系统疾病已 与神经系统组织损伤有关 促炎细胞因子和其他可溶性因子 激活的单核吞噬细胞(MP)。在本提案中,我们将研究 类维生素A抑制免疫系统促炎活性的机制 来自艾滋病毒感染者和免疫细胞系的细胞。类维生素A, 维生素 A 相关化合物已被证明可以抑制这种现象 免疫活性,并且在 m -1 感染的研究中,可以抑制复制 受感染的单核细胞系中的病毒。 HIV-1 (HIV) 感染者 感染,维生素 A 缺乏与感染风险增加有关 出现与艾滋病毒相关的并发症。然而,在大多数情况下, 临床试验中服用维生素 A 尚未发现与 HIV相关临床参数的改善。我们之前的研究表明 1) 血浆中维生素A代谢参数较低 HIV 感染者的比例高于未感染者,这表明 脑脊液中可观察到异常; 2)血浆视黄醇水平较低 患有慢性炎症性神经系统疾病的血清阴性患者比 患有非炎症性神经系统疾病的对照受试者和治疗 这些具有免疫调节剂的个体与特定的 对类维生素A受体亚型表达模式的影响; 3) 类视黄醇化合物 抑制外周血免疫细胞产生促炎细胞因子 和细胞系,并且在细胞系中,类维生素A诱导的抑制 细胞同时暴露于吗啡或 可卡因。因此,我们提出本提案的以下目标:1) 通过单核细胞检查促炎细胞因子(TNF-a)的表达 来自阿片类药物使用者和有或没有艾滋病毒病史的非吸毒者的细胞 感染; 2) 检查特定视黄醇受体激活的影响 对类维生素A暴露的单核细胞系引起的免疫效应的影响; 3) 检查滥用物质(吗啡和可卡因)对人的影响 类维生素A受体激动剂和受体诱导的特异性免疫反应 单核细胞系中的拮抗剂; 4) 并评估其作用 类视黄醇和物质作用中抑制核 NF-KB 结合 滥用患者细胞产生的促炎细胞因子和 单核细胞系。这些研究将加深我们对 类视黄醇化合物对 HIV 感染者的免疫影响,并且可能 从而找到治疗感染及其相关疾病的有效方法 维生素A引起的并发症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WALTER ROYAL其他文献

WALTER ROYAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WALTER ROYAL', 18)}}的其他基金

Nicotinic Acid Receptor Activation and Brain Proinflammatory Responses in HIV-1 Transgenic Rat
HIV-1 转基因大鼠烟酸受体激活和脑促炎反应
  • 批准号:
    10160861
  • 财政年份:
    2018
  • 资助金额:
    $ 34.14万
  • 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
  • 批准号:
    9897455
  • 财政年份:
    2017
  • 资助金额:
    $ 34.14万
  • 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
  • 批准号:
    10083681
  • 财政年份:
    2017
  • 资助金额:
    $ 34.14万
  • 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
  • 批准号:
    10341091
  • 财政年份:
    2017
  • 资助金额:
    $ 34.14万
  • 项目类别:
Mechanisms of NAD Metabolism and Chronic Inflammation in HIV-1 Transgenic Rat Models
HIV-1转基因大鼠模型中NAD代谢和慢性炎症的机制
  • 批准号:
    9242303
  • 财政年份:
    2017
  • 资助金额:
    $ 34.14万
  • 项目类别:
Studies of Cigarette Smoke Exposure in an Animal Model of HIV-1 Infection
HIV-1 感染动物模型中香烟烟雾暴露的研究
  • 批准号:
    8624954
  • 财政年份:
    2013
  • 资助金额:
    $ 34.14万
  • 项目类别:
Studies of Cigarette Smoke Exposure in an Animal Model of HIV-1 Infection
HIV-1 感染动物模型中香烟烟雾暴露的研究
  • 批准号:
    8735918
  • 财政年份:
    2013
  • 资助金额:
    $ 34.14万
  • 项目类别:
Physical Telerahabilitation in Veterans with Multiple Sclerosis
患有多发性硬化症的退伍军人的身体远程康复
  • 批准号:
    8838115
  • 财政年份:
    2012
  • 资助金额:
    $ 34.14万
  • 项目类别:
Physical Telerahabilitation in Veterans with Multiple Sclerosis
患有多发性硬化症的退伍军人的身体远程康复
  • 批准号:
    8499086
  • 财政年份:
    2012
  • 资助金额:
    $ 34.14万
  • 项目类别:
Physical Telerahabilitation in Veterans with Multiple Sclerosis
患有多发性硬化症的退伍军人的身体远程康复
  • 批准号:
    8277575
  • 财政年份:
    2012
  • 资助金额:
    $ 34.14万
  • 项目类别:

相似海外基金

Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
  • 批准号:
    23K06731
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
  • 批准号:
    23K06616
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
  • 批准号:
    10597799
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
  • 批准号:
    EP/Y024591/1
  • 财政年份:
    2023
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10672364
  • 财政年份:
    2022
  • 资助金额:
    $ 34.14万
  • 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
  • 批准号:
    10385037
  • 财政年份:
    2022
  • 资助金额:
    $ 34.14万
  • 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
  • 批准号:
    10383462
  • 财政年份:
    2022
  • 资助金额:
    $ 34.14万
  • 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
  • 批准号:
    10483063
  • 财政年份:
    2022
  • 资助金额:
    $ 34.14万
  • 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
  • 批准号:
    2752732
  • 财政年份:
    2022
  • 资助金额:
    $ 34.14万
  • 项目类别:
    Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10546865
  • 财政年份:
    2022
  • 资助金额:
    $ 34.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了